Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.61% | 77.73 | 1.0% | $1898.73m | |
| AMGN | Amgen, Inc. | 3.00% | 211.58 | 1.3% | $929.21m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.22% | 504.27 | 2.6% | $852.10m | |
| BIIB | Biogen, Inc. | 3.62% | 311.39 | 1.5% | $796.11m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 7.13% | 255.30 | 1.9% | $652.54m | |
| MRNA | Moderna, Inc. | -0.57% | 34.64 | 0.0% | $571.40m | |
| ILMN | Illumina, Inc. | 5.51% | 278.01 | 3.5% | $493.14m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 6.84% | 95.91 | 2.0% | $303.02m | |
| A | Agilent Technologies, Inc. | 5.47% | 74.28 | 1.6% | $229.86m | |
| INCY | Incyte Corp. | 8.30% | 85.11 | 2.5% | $212.70m | |
| EXAS | EXACT Sciences Corp. | 11.70% | 62.27 | 21.0% | $179.74m | |
| SGEN | Seattle Genetics, Inc. | 6.83% | 124.47 | 6.1% | $170.36m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.71% | 82.77 | 4.3% | $160.44m | |
| NVAX | Novavax, Inc. | 3.14% | 16.10 | 114.7% | $125.40m | |
| IMMU | Immunomedics, Inc. | 99.79% | 18.78 | 11.9% | $114.76m |
Company Profile
BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.